Article
Multidisciplinary treatment of gastrointestinal stromal tumors.
The Surgical clinics of North America - 1 Feb 2009
Kingham T Peter, DeMatteo Ronald P
Abstract excerpt
Gastrointestinal stromal tumor (GIST) has been recognized as a unique tumor only in the last decade. Although rare as a clinical entity, there is much interest in the pathology and treatment because the KIT protooncogene mutation common to most GISTs can be inhibited by imatinib mesylate. Diagnosing and treating GIST requires a multidisciplinary approach, given the combination of pathologic and radiographic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
